Next Article in Journal
Climate Change Adaptation Strategies at a Local Scale: The Portuguese Case Study
Previous Article in Journal
Spatial Pattern and Influencing Factors of Tourism Resources in Northwestern Ethnic Areas in China—A Case Study of Longde County
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 19
Issue 24
10.3390/ijerph192416685
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Triptolide Attenuates Muscular Inflammation and Oxidative Stress in a Delayed-Onset Muscle Soreness Animal Model

by
Che-Chia Hsu
1,†,
Chin-Chuan Tsai
2,3,†,
Po-Yen Ko
1,
Ting-Hsien Kwan
4,
Ming-Yie Liu
5,
Po-Ting Wu
1,6,7,8,9,* and
I-Ming Jou
10,11,12,*
1
Department of Orthopaedics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70428, Taiwan
2
Department of Traditional Chinese Medicine, E-Da Dachang Hospital, Kaohsiung 82445, Taiwan
3
School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung 82445, Taiwan
4
Department of Orthopaedics, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 60002, Taiwan
5
Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 70428, Taiwan
6
Medical Device Innovation Center, National Cheng Kung University, Tainan 70428, Taiwan
7
Department of Orthopaedics, College of Medicine, National Cheng Kung University, Tainan 70428, Taiwan
8
Department of Biomedical Engineering, National Cheng Kung University, Tainan 70428, Taiwan
9
Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan 70428, Taiwan
10
Department of Orthopaedics, E-Da Hospital, Kaohsiung 82445, Taiwan
11
School of Medicine, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan
12
GEG Orthopedic Clinic, Tainan 74543, Taiwan
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to the work.
Int. J. Environ. Res. Public Health 2022, 19(24), 16685; https://doi.org/10.3390/ijerph192416685
Submission received: 14 November 2022 / Revised: 7 December 2022 / Accepted: 8 December 2022 / Published: 12 December 2022
(This article belongs to the Special Issue Treatment and Healthcare of Musculoskeletal Disorders)
Browse Figures
Review Reports Versions Notes

Abstract

:
Delayed-onset muscle soreness (DOMS) is associated with exercise-induced muscle damage and inflammation, which is mainly caused by prolonged eccentric exercise in humans. Triptolide, an extract from the Chinese herb Tripterygium wilfordii Hook F, has been used for treating autoimmune and inflammatory diseases in clinical practice. However, whether triptolide attenuates acute muscle damage is still unclear. Here, we examined the effect of triptolide on carrageenan-induced DOMS in rats. Rats were injected with 3% of carrageenan into their muscles to induce acute left gastrocnemius muscular damage, and triptolide treatment attenuated carrageenan-induced acute muscular damage without affecting hepatic function. Triptolide can significantly decrease lipid hydroperoxide and nitric oxide (NO) levels, proinflammatory cytokine production, and the activation of nuclear factor (NF)-ĸB, as well as increase a reduced form of glutathione levels in carrageenan-treated rat muscles. At the enzyme levels, triptolide reduced the inducible nitric oxide synthase (iNOS) expression and muscular myeloperoxidase (MPO) activity in carrageenan-treated DOMS rats. In conclusion, we show that triptolide can attenuate muscular damage by inhibiting muscular oxidative stress and inflammation in a carrageenan-induced rat DOMS model.

1. Introduction

Delayed-onset muscle soreness (DOMS) is a symptom of prolonged eccentric exercise-associated muscle injury and inflammation [1]. In DOMS, muscle fiber microtrauma leads to an adaption of muscle to prevent damage, thereby causing soreness [1]. DOMS is commonly observed in athletes and people who are undergoing eccentric exercise [1]. Emerging evidence indicates that oxidative stress plays a central role in the initiation and perpetuation of inflammatory responses, which are involved in the pathophysiological changes of various diseases, including cardiovascular disease, diabetes, and cancers [2]. Over-production of free radicals (superoxide anions, hydroxyl radicals, and nitric oxide) and reduced levels of circulating antioxidants (reduced form of glutathione, GSH) predominantly account for muscular oxidative stress [3]. In order to develop effective therapeutics for DOMS, oxidative stress and inflammation in DOMS should be considered.
At the molecular level, several oxidative stress-associated proteins may be involved in this distinct process. Inducible NO synthase (iNOS)-produced nitric oxide (NO) is one of the reactive nitrogen species that has been reported to be involved in the pathogenesis of both oxidative stress and inflammation [4,5]. Furthermore, NO enhances the activity of nuclear factor (NF)-ĸB [6,7] and the generation of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF)-α and interleukin (IL)-1β [8,9]. Myeloperoxidase (MPO), a highly expressed protein in neutrophils, plays a primary role in leukocyte-mediated host defenses [10]. MPO is known to contribute to oxidative damages in many inflammatory disorders [11,12] and can increase iNOS activity by blocking NO-exerted feedback action on iNOS [13]. Up to the present, these molecules have not been studied together in DOMS before.
Tripterygium wilfordii Hook F (TWHF), a traditional Chinese herb, has a long history of being used to treat a variety of inflammatory disorders that dates back many centuries [14,15,16]. Triptolide, as well as extract from TWHF, have been tested in various models of inflammatory and autoimmune disorders, including nephritis, asthma, arthritis, and neurodegenerative disorders, and they have been found to modulate a variety of inflammatory mediators [17]. For instance, triptolide can exert its anti-hepatofibrotic effects in animal models of liver fibrosis and can inhibit the NF-κB signaling pathway in hepatic stellate cells [18]. Wang et al. also demonstrated the anti-inflammatory effects of triptolide through inhibiting the NF-κB signaling pathway in an LPS-induced acute lung injury murine model [19]. Triptolide can inhibit superoxide anion and reactive oxygen species’ (ROS) production in murine peritoneal macrophages by down-regulating NF-κB activation [20,21] and suppress ROS generation and p38 mitogen-activated protein kinase (MAPK) activation in C5b-9-induced podocytes [22]. However, the application of triptolide in acute muscle damage remains elusive. The aim of the present study is to examine the therapeutic effect of triptolide on a rat model of acute muscle damage and examine its possible mechanism.

2. Materials and Methods

2.1. DOMS Animal Model

Male Sprague Dawley rats were obtained from and housed in our institution’s laboratory animal center. They were housed individually in a room with a 12/12-h light/dark cycle and with central air conditioning (25 °C, 70% humidity). The animal care and experimental protocols were in accordance with institutional guidelines, which were approved by the National Cheng Kung University Animal Center (Approval number: 105035). For inducing acute muscular damage in rats, carrageenan, purchased from Sigma (Cat.#C1013, St Louis, MO, USA), was injected in the amount of 100 μL of 3% carrageenan into rats’ left gastrocnemius muscle under isoflurane (3%) anesthesia, as published previously [23].

2.2. In Vivo Study Design

Thirty rats were divided into five groups. In the normal (N) group, rats received 100 μL of saline by gastrocnemius muscle injection into the left limbs and 500 μL of saline by intraperitoneal (i.p.) injection; in the control (C) group, rats received 100 μL of 3% carrageenan (Sigma-Aldrich, St Louis, MO, USA) by gastrocnemius muscle injection into the left limbs and 500 μL of saline by i.p. injection; and in the CT30, 100, and 300 groups, rats received 100 μL of 3% carrageenan by gastrocnemius muscle injection into the left limbs and 500 μL of triptolide (Cat.#T3652, Sigma-Aldrich, St Louis, MO, 30, 100, and 300 mg/kg) by i.p. injection. Six hours after the above treatments, a pan behavior test was performed in each rat. After this, rats were euthanized, and their serum and muscle tissue samples were collected for further analyses.

2.3. Pain Behavior Test

Rat muscle pain was assessed using an incapacitance meter (IITC, Inc., Woodland Hills, CA, USA), which is a behavioral analysis assay that measures weight bearing on the hindlimbs while the animal is in an induced rearing posture. In brief, it is an in-capacitance meter that consists of two scales and a specialized cage to encourage a rearing posture. Hindlimb weight bearing was tracked and recorded over a 3 min period. These data were transformed into weight distribution by dividing the weight on the right limb by the total weight of both hindlimbs [24].

2.4. Serum Biochemical Analysis

Serum biochemical changes, including lactate dehydrogenase (LDH), creatine phosphokinase (CPK), glutamate oxaloacetate transaminase (GOT), and glutamate-pyruvate transaminase (GPT), were assessed by a serum biochemical analyzer (DRI-CHEM 3500s; Fujifilm, Kanagawa, Japan).

2.5. Western Blot

We used a nuclear extraction kit (Cat.#NXTRACT, Sigma, Inc., St. Louis, MO) to separate nuclear and cytosolic proteins in the muscle tissues. Fifty micrograms of proteins were used to perform sodium dodecyl sulfate polyacrylamide gel electrophoresis, and the blot was obtained in transferred nitrocellulose sheets (Cat.#NBA085B001EA, NEN Life Science Products, Inc., Boston, MA, USA). After blocking in 5% non-fat skim milk, NF-ĸB p65 (Cat.#SC-8008, Santa Cruz Biotechnology, Dallas, TX, USA), phospho-IĸB (Serine 32, Cat.#SC -8404, Santa Cruz Biotechnology, Dallas, TX), iNOS (Cat.#ab283655, Abcam, Cambridge, UK), and GAPDH (Cat.#32233, Santa Cruz Biotechnology, Dallas, TX, USA) antibodies (dilution 1:1500) were added and incubated at 4 °C overnight. Then, secondary antibodies conjugated with alkaline phosphatase (dilution 1:2000) (Cat.#111-055-003 and 111-055-146, Jackson ImmunoResearch Laboratories, Inc., Philadelphia, PA, USA) were added onto the blots. Immunoblots were observed after bromochloroindolyl phosphate/nitroblue tetrazolium solution was added (Cat.#5410-0013, Kirkegaard and Perry Laboratories, Inc., Baltimore, MD, USA) [25].

2.6. Measuring Lipid Peroxidation Level in Muscle

Muscle tissues were homogenized in Milli-Q water. Tissue homogenates (500 μL) were centrifuged at 2500× g for 10 min at 4 °C. Five hundred μL of supernatant was sent for lipid hydroperoxide measurement using a kit (Cat.#ab133085, Lipid Hydroperoxide Assay Kit, Abcam, Cambridge, UK), according to the manufacturer’s instruction.

2.7. Measuring Muscular Glutathione (GSH) Level

Muscle tissues were homogenized in 10% of ice-cold trichloroacetic acid and then centrifuged at 3000 rpm for 10 min. Supernatant (500 μL) was added to 2 mL of 0.3 M Na2HPO4 solution. After adding 200 μL of dithiobisnitrobenzoate solution, the absorbance at 412 nm was measured immediately, as described previously [26].

2.8. Measuring Pro-Inflammatory Cytokines in Muscles

Levels of TNF-α and IL-1β in muscle tissue homogenates were measured using enzyme-linked immunosorbent assay (ELISA) kits (Cat.#DY510 and DY501, DuoSet; R&D Systems Inc., Minneapolis, MN, USA), according to the manufacturer’s instruction.

2.9. Measuring Nitrite Concentration

The amounts of nitrite in muscle tissue were measured by incubating 100 μL of tissue homogenates with 100 μL of Griess solution and using a spectrophotometer at an absorbance of 550 nm. Further, sodium nitrite was prepared as the standard solution, as described previously [27].

2.10. Histological Evaluation of Muscular Injury

Muscle tissues were fixed in 4% formaldehyde. Tissue fragments were washed in phosphate buffer, dehydrated in graded concentrations of ethanol, and then embedded in paraffin. From each tissue, 4 µm sections were prepared and stained with hematoxylin and eosin to evaluate muscular morphology. The inflammation score was evaluated as published previously, where 0: none; 1: giant cells, lymphocytes, plasma cells; 2: giant cells, eosinophil, neutrophil; 3: many inflammatory cells [28].

2.11. Measuring Hepatic MPO Activity

Muscle tissues were homogenized in 20 mM phosphate buffer (pH 7.4) and then centrifuged (13,000 rpm for 10 min at 4 °C). The pellet was resuspended in 1 mL of 50 mM phosphate buffer containing 0.5% hexadecyltrimethylammonium bromide. The suspension was subjected to four cycles of freezing and thawing, and then centrifuged (13,000 rpm for 5 min at 4 °C). Supernatant (0.5 mL) was mixed with tetramethylbenzidine (0.5 mL) and incubated for 1 min. The reaction was stopped by adding 0.5 mL of 2 N H2SO4. The spectrophotometer was then used for measurement at an absorbance of 405 nm. MPO activity is shown as the absorbance at 405 nm/min/mg protein, as published previously [29].

2.12. Statistical Analysis

Data are means ± standard deviation (SD). Group comparisons were performed using SPSS statistical software (SPSS Institute, Chicago, IL, USA). One-way ANOVA followed by Dunnett’s multiple comparison tests was used for among-group comparison. Statistical significance was set at a p value less than 0.05.

3. Results

3.1. Triptolide Reduces Pain, Serum LDH and CPK Levels without Affecting Hepatic Function in the DOMS Rat Model

To examine the effects of triptolide on muscle damage and hepatic function, serum LDH, CPK, GOT, and GPT levels were determined in carrageenan-treated rats. Carrageenan increased serum LDH (Figure 1A) and CPK (Figure 1B) levels, whereas triptolide significantly decreased their levels at a dose of 100 or 300 mg/kg compared with the carrageenan control group. However, neither carrageenan nor triptolide altered the levels of GOT (Figure 1C) and GPT (Figure 1D). In addition, carrageenan decreased the percentage of weight bearing in rats, whereas triptolide significantly increased this at a dose of 300 mg/kg compared with the C group (Figure 2).

3.2. Triptolide Suppresses NO, iNOS, Reactive Nitrogen Species (RNS), and MPO Expression and Oxidative Stress in the DOMS Rat Model

To examine the involvement of reactive nitrogen species (RNS) in triptolide-exerted muscular protection, NO levels were determined in carrageenan-treated rats. Carrageenan significantly increased muscular NO concentration, whereas triptolide at a dose of 300 mg/kg decreased it compared with the carrageenan control group (Figure 3A). In addition, carrageenan increased the expression of iNOS, and triptolide at a dose of 300 mg/kg significantly decreased this when compared with the carrageenan control groups (Figure 3B). To assess the role of MPO in triptolide-associated anti-oxidative effects against carrageenan, muscular MPO activity was determined. Carrageenan significantly increased the activity of muscular MPO compared with the normal group. Triptolide at doses of 100 and 300 mg/kg significantly reduced the MPO activities compared with the carrageenan control group (Figure 3C).
To examine the involvement of oxidative stress in triptolide-treated DOMS rats, muscular lipid hydroperoxide and GSH levels were determined. Carrageenan increased lipid hydroperoxide but decreased GSH levels in carrageenan-treated muscles compared with normal controls; however, triptolide significantly reversed these patterns (Figure 3D,E).

3.3. Triptolide Decreases Expression Levels of TNF-α, IL-1β, Nuclear NF-ĸB, and Leukocyte Infiltration in the DOMS Rat Model

To examine the effect of triptolide on carrageenan-induced muscular inflammation, muscular pro-inflammatory cytokine levels and the expressions of NF-ĸB and IĸB were determined. Carrageenan significantly increased muscular TNF-α (Figure 4A) and IL-1β (Figure 4B) levels compared with the normal group; however, triptolide significantly attenuated carrageenan-induced pro-inflammatory cytokine expressions at doses of 100 and 300 mg/kg compared with those in the carrageenan-treated group (Figure 4A,B). Furthermore, both nuclear NF-ĸB (Figure 4C) and p-IĸB (Figure 4D) expressions were increased compared with the normal group, whereas triptolide significantly reduced these expressions at doses of 100 and 300 mg/kg compared with the carrageenan control groups (Figure 4C,D). In the histological examination, increased inflammatory cell infiltration into muscles was observed in the carrageenan control group (Figure 5B); however, mild infiltration was found in muscle tissues from rats treated with 30 (Figure 5C) and 100 (Figure 5D) mg/kg of triptolide. Very little inflammatory cell filtration was found in the muscle tissues from the normal group (Figure 5A) and the group treated with 300 mg/kg of triptolide (Figure 5E). The groups treated with 100 and 300 mg/kg of triptolide had significantly lower inflammation scores than the carrageenan control group (Figure 5F).

4. Discussion

In this study, we demonstrate that the natural product extract triptolide attenuates pain levels, as well as muscular inflammation and oxidative stress, without affecting hepatic function in a DOMS rat model. Triptolide decreased muscular proinflammatory cytokine release and neutrophil infiltration. Triptolide can also reduce muscular oxidative stress, NO production, and iNOS expression in carrageenan-treated rat muscles. Furthermore, triptolide inhibits the activation of NF-ĸB and muscular MPO activity. We suggested that triptolide could protect carrageenan-induced muscles from oxidative stress-induced damage and inactivate NF-ĸB-mediated proinflammatory cytokine expression.
As a pain-producing stimulus, carrageenan, an extract from seaweed, has been widely used in assessing inflammatory pain in various animal models. It induces gastrocnemius injury that is recognized as a simplified model of muscle inflammation characterized by delayed-onset muscle soreness, a reduction in grip force, and pain [30]. In the present study, we used intramuscular injections of carrageenan to produce muscular inflammation for mimicking DOMS in rodents.
Inflammation and oxidative stress have been implicated in the pathogenesis and development of various acute muscle damages [31,32]. Carrageenan has been shown to elicit a local inflammation when injected into muscles, as evidenced by the accumulation of leukocytes that began 2 h post-injection and lasted for the next 8 h [33]. In the present study, triptolide significantly decreased muscular pro-inflammatory cytokine production and inflammatory cell filtration 6 h after administration, as well as the lipid hydroperoxide level, which is a specific biomarker of oxidative stress in carrageenan-induced muscle damage. Free radical-initiated oxidative stress has been reported to participate in the pathogenesis of inflammatory disorders from various animal studies [34]. Among the free radicals, NO, a reactive nitrogen species, is one of the important free radicals participating in the pathogenesis and development of oxidative stress [35]. NO reacts with superoxide anion to form peroxynitrite, a highly cytotoxic free radical [36]. On the other hand, NO also plays a crucial role in regulating inflammatory response [37]. During inflammation, activating NF-ĸB enhances the transcription of pro-inflammatory mediators, such as NO, TNF-α, and IL-1β [38]. However, NO sustains the activation of NF-ĸB in chondrocytes and macrophages [6,39]. Taken together, we suggest that the activation of NF-ĸB could be down-regulated by triptolide-associated iNOS inhibition in carrageenan-induced muscle inflammation.
Triptolide can inhibit iNOS expression via a reduction in MPO activity. NO reduces the catalytic activity of iNOS by competing with O2 at the catalytic site of the enzyme during catalysis, which generates inactive NOS–nitrosyl complexes [40,41]. However, MPO can be secreted from the primary granules and colocalized with iNOS in activated leukocytes [42], which up-regulates the catalytic activity of iNOS by preventing feedback inhibition of NO [43,44,45]. We showed that triptolide significantly decreased muscular iNOS expression and MPO activity, suggesting that inhibiting MPO activity is crucial in the protective effect of triptolide from carrageenan-induced acute muscle damage.
LDH and CPK are the fragments of the myosin heavy chain, both of which cannot cross the sarcoplasmic membrane barrier [46,47]. Therefore, increased serum concentrations of the two molecules are indicators of damage to muscle membrane [48]. Although it has been reported to have hepatoxicity [49], in the present study, triptolide at the therapeutic doses significantly decreased LDH and CPK serum levels without affecting GOT and GPT. Both are the biomarkers of hepatic function. We suggest that triptolide might have a clinical application for the patients with acute muscle inflammation.

5. Conclusions

In conclusion, we have shown that the traditional Chinese herb extract triptolide can attenuate muscle inflammation by inhibiting MPO-associated oxidative stress in carrageenan-induced DOMS in rats without obvious adverse events.

Author Contributions

Conceptualization, C.-C.H., C.-C.T., P.-T.W. and I.-M.J.; methodology, C.-C.H., P.-Y.K., T.-H.K., M.-Y.L. and I.-M.J.; validation, C.-C.H., C.-C.T., P.-T.W. and I.-M.J.; formal analysis, C.-C.H., C.-C.T., P.-Y.K., T.-H.K., P.-T.W. and I.-M.J.; investigation, C.-C.H., C.-C.T., P.-T.W. and I.-M.J.; resources, P.-T.W. and I.-M.J.; data curation, C.-C.H., C.-C.T., P.-Y.K., T.-H.K., M.-Y.L., P.-T.W. and I.-M.J.; writing—original draft preparation, C.-C.H., C.-C.T., P.-T.W. and I.-M.J.; writing—review and editing, C.-C.H., C.-C.T., P.-T.W. and I.-M.J.; visualization, C.-C.H., C.-C.T., P.-T.W. and I.-M.J.; supervision, C.-C.H., P.-T.W. and I.-M.J.; project administration, P.-T.W. and I.-M.J.; funding acquisition, C.-C.H., P.-Y.K., M.-Y.L., P.-T.W. and I.-M.J. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Taiwan National Science and Technology Council (grants: MOST 110-2314-B-006-022, MOST 111-2314-B-006-054, MOST108-2314-B-006-011-MY2, and MOST 109-2314-B-650-004), National Cheng Kung University (grants: NCKUEDA10607, NCKUEDA10617, NCKUEDA10814 and NCKUEDA11103), National Cheng Kung University Hospital (NCKUH-11104037 and NCKUH-11104069) and E-Da hospital (EDAPJ109079).

Institutional Review Board Statement

The animal study protocol was approved by the Institutional Animal Care and Use Committee of National Cheng Kung University (protocol code 105035). Animal experiments were conducted in accordance with the approved institutional guidelines.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author.

Acknowledgments

We are grateful to Skeleton Materials and Bio-compatibility Core Lab, Clinical Medicine Research Center, National Cheng Kung University Hospital for assistance with this study. We also wish to thank Dur-Zong Hsu and Yu-Ying Chen for their valuable administrative assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Meamarbashi, A. Herbs and natural supplements in the prevention and treatment of delayed-onset muscle soreness. Avicenna J. Phytomedicine 2017, 7, 16. [Google Scholar]
  2. Lugrin, J.; Rosenblatt-Velin, N.; Parapanov, R.; Liaudet, L. The role of oxidative stress during inflammatory processes. Biol. Chem. 2014, 395, 203–230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Saborido, A.; Naudí, A.; Portero-Otín, M.; Pamplona, R.; Megías, A. Stanozolol treatment decreases the mitochondrial ROS generation and oxidative stress induced by acute exercise in rat skeletal muscle. J. Appl. Physiol. 2011, 110, 661–669. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Gliozzi, M.; Scicchitano, M.; Bosco, F.; Musolino, V.; Carresi, C.; Scarano, F.; Maiuolo, J.; Nucera, S.; Maretta, A.; Paone, S.; et al. Modulation of nitric oxide synthases by oxidized LDLs: Role in vascular inflammation and atherosclerosis development. Int. J. Mol. Sci. 2019, 20, 3294. [Google Scholar] [CrossRef] [Green Version]
  5. Conti, A.; Miscusi, M.; Cardali, S.M.; Germanò, A.; Suzuki, H.; Cuzzocrea, S.; Tomasello, F. Nitric oxide in the injured spinal cord: Synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 2007, 54, 205–218. [Google Scholar] [CrossRef]
  6. Clancy, R.; Gomez, P.; Abramson, S. Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes. Osteoarthr. Cartil. 2004, 12, 552–558. [Google Scholar] [CrossRef] [Green Version]
  7. Yu, S.M.; Han, Y.; Kim, S.J. Simvastatin abolishes nitric oxide-and reactive oxygen species-induced cyclooxygenase-2 expression by blocking the nuclear factor κB pathway in rabbit articular chondrocytes. Cell Biol. Int. 2020, 44, 2153–2162. [Google Scholar] [CrossRef]
  8. Dong, G.K.; Zhang, X.T.; Ma, L.Q.; Li, N.; Ma, C.L.; Cong, B.; Gu, Z.Y. Nitric oxide mediated TNF-α, IL-1β gene expression in liver induced by crush injury of rat’s soft tissues. Fa Yi Xue Za Zhi 2014, 30, 250–252. [Google Scholar]
  9. Vuolteenaho, K.; Moilanen, T.; Knowles, R.; Moilanen, E. The role of nitric oxide in osteoarthritis. Scand. J. Rheumatol. 2007, 36, 247–258. [Google Scholar] [CrossRef]
  10. Klebanoff, S. Peroxidases in Chemistry and Biology; CRC Press: Boca Raton, FL, USA, 1991; pp. 1–35. [Google Scholar]
  11. Deby-Dupont, G.; Deby, C.; Lamy, M. Neutrophil myeloperoxidase revisited: It’s role in health and disease. Intensivmed. Und Notf. 1999, 36, 500–513. [Google Scholar] [CrossRef]
  12. Heinecke, J.W. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J. Lab. Clin. Med. 1999, 133, 321–325. [Google Scholar] [CrossRef] [PubMed]
  13. Galijasevic, S.; Saed, G.M.; Diamond, M.P.; Abu-Soud, H.M. Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition. Proc. Natl. Acad. Sci. USA 2003, 100, 14766–14771. [Google Scholar] [CrossRef] [PubMed]
  14. Lv, Q.W.; Zhang, W.; Shi, Q.; Zheng, W.J.; Li, X.; Chen, H.; Wu, Q.-J.; Jiang, W.-L.; Li, H.B.; Gong, L.; et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): A randomised, controlled clinical trial. Ann. Rheum. Dis. 2015, 74, 1078–1086. [Google Scholar] [CrossRef] [PubMed]
  15. Goldbach-Mansky, R.; Wilson, M.; Fleischmann, R.; Olsen, N.; Silverfield, J.; Kempf, P.; Kivitz, A.; Sherrer, Y.; Pucino, F.; Csako, G.; et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: A randomized trial. Ann. Intern. Med. 2009, 151, 229–240. [Google Scholar] [CrossRef] [Green Version]
  16. Tao, X.; Davis, L.S.; Lipsky, P.E. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 1991, 34, 1274–1281. [Google Scholar] [CrossRef]
  17. Yuan, K.; Li, X.; Lu, Q.; Zhu, Q.; Jiang, H.; Wang, T.; Huang, G.; Xu, A. Application and mechanisms of triptolide in the treatment of inflammatory diseases—A review. Front. Pharmacol. 2019, 10, 1469. [Google Scholar] [CrossRef] [Green Version]
  18. Chong, L.W.; Hsu, Y.C.; Chiu, Y.T.; Yang, K.C.; Huang, Y.T. Antifibrotic Effects of Triptolide on Hepatic Stellate Cells and Dimethylnitrosamine-intoxicated Rats. Phytother. Res. 2011, 25, 990–999. [Google Scholar] [CrossRef]
  19. Wang, X.; Zhang, L.; Duan, W.; Liu, B.; Gong, P.; Ding, Y.; Wu, X. Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model. Mol. Med. Rep. 2014, 10, 447–452. [Google Scholar] [CrossRef] [Green Version]
  20. Wang, B.; Ma, L.; Tao, X.; Lipsky, P. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 2004, 50, 2995–3003. [Google Scholar] [CrossRef]
  21. Wu, Y.; Cui, J.; Bao, X.; Chan, S.; Young, D.O.; Liu, D.; Shen, P. Triptolide attenuates oxidative stress, NF-κB activation and multiple cytokine gene expression in murine peritoneal macrophage. Int. J. Mol. Med. 2006, 17, 141–150. [Google Scholar] [CrossRef]
  22. Chen, Z.-H.; Qin, W.-S.; Zeng, C.-H.; Zheng, C.-X.; Hong, Y.-M.; Lu, Y.-Z.; Li, L.-S.; Liu, Z.-H. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Kidney Int. 2010, 77, 974–988. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Radhakrishnan, R.; Moore, S.A.; Sluka, K.A. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain 2003, 104, 567–577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Philpott, H.T.; O’Brien, M.; McDougall, J.J. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain 2017, 158, 2442. [Google Scholar] [CrossRef] [PubMed]
  25. Chu, P.-Y.; Chien, S.-P.; Hsu, D.-Z.; Liu, M.-Y. Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats. Food Chem. Toxicol. 2010, 48, 1821–1826. [Google Scholar] [CrossRef] [PubMed]
  26. Hsu, D.Z.; Chien, S.P.; Li, Y.H.; Chuang, Y.C.; Chang, Y.C.; Liu, M.Y. Sesame oil attenuates hepatic lipid peroxidation by inhibiting nitric oxide and superoxide anion generation in septic rats. J. Parenter. Enter. Nutr. 2008, 32, 154–159. [Google Scholar] [CrossRef] [PubMed]
  27. Periasamy, S.; Hsu, D.-Z.; Fu, Y.-H.; Liu, M.-Y. Sleep deprivation-induced multi-organ injury: Role of oxidative stress and inflammation. Excli J. 2015, 14, 672. [Google Scholar]
  28. Huang, S.-C.; Wu, J.-F.; Saovieng, S.; Chien, W.-H.; Hsu, M.-F.; Li, X.-F.; Lee, S.-D.; Huang, C.-Y.; Kuo, C.-H. Doxorubicin inhibits muscle inflammation after eccentric exercise. J. Cachexia Sarcopenia Muscle 2017, 8, 277–284. [Google Scholar] [CrossRef]
  29. Ng, S.W.; Zhang, H.; Hegde, A.; Bhatia, M. Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia. J. Leukoc. Biol. 2008, 83, 288–295. [Google Scholar] [CrossRef] [Green Version]
  30. Kehl, L.J.; Fairbanks, C.A. Experimental animal models of muscle pain and analgesia. Exerc. Sport Sci. Rev. 2003, 31, 188–194. [Google Scholar] [CrossRef] [Green Version]
  31. Kim, M.; Chun, J.; Jung, H.A.; Choi, J.S.; Kim, Y.S. Capillarisin attenuates exercise-induced muscle damage through MAPK and NF-κB signaling. Phytomedicine 2017, 32, 30–36. [Google Scholar] [CrossRef]
  32. Withee, E.D.; Tippens, K.M.; Dehen, R.; Tibbitts, D.; Hanes, D.; Zwickey, H. Effects of Methylsulfonylmethane (MSM) on exercise-induced oxidative stress, muscle damage, and pain following a half-marathon: A double-blind, randomized, placebo-controlled trial. J. Int. Soc. Sport. Nutr. 2017, 14, 24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Diehl, B.; Hoheisel, U.; Mense, S. Histological and neurophysiological changes induced by carrageenan in skeletal muscle of cat and rat. Agents Actions 1988, 25, 210–213. [Google Scholar] [CrossRef] [PubMed]
  34. Pérez-Torres, I.; Guarner-Lans, V.; Rubio-Ruiz, M.E. Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents. Int. J. Mol. Sci. 2017, 18, 2098. [Google Scholar] [CrossRef] [PubMed]
  35. Bloodsworth, A.; O’Donnell, V.B.; Freeman, B.A. Nitric oxide regulation of free radical–and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1707–1715. [Google Scholar] [CrossRef] [Green Version]
  36. Halliwell, B.; Zhao, K.; Whiteman, M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: A personal view of recent controversies. Free Radic. Res. 1999, 31, 651–669. [Google Scholar] [CrossRef]
  37. Guzik, T.; Korbut, R.; Adamek-Guzik, T. Nitric oxide and superoxide in inflammation. J. Physiol. Pharm. 2003, 54, 469–487. [Google Scholar]
  38. DiDonato, J.A.; Mercurio, F.; Karin, M. NF-κB and the link between inflammation and cancer. Immunol. Rev. 2012, 246, 379–400. [Google Scholar] [CrossRef]
  39. Kang, J.L.; Lee, K.; Castranova, V. Nitric oxide up-regulates DNA-binding activity of nuclear factor-κB in macrophages stimulated with silica and inflammatory stimulants. Mol. Cell. Biochem. 2000, 215, 1–9. [Google Scholar] [CrossRef]
  40. Wang, J.; Rousseau, D.L.; Abu-Soud, H.M.; Stuehr, D.J. Heme coordination of NO in NO synthase. Proc. Natl. Acad. Sci. USA 1994, 91, 10512–10516. [Google Scholar] [CrossRef] [Green Version]
  41. Hurshman, A.R.; Marletta, M.A. Nitric oxide complexes of inducible nitric oxide synthase: Spectral characterization and effect on catalytic activity. Biochemistry 1995, 34, 5627–5634. [Google Scholar] [CrossRef]
  42. Evans, T.; Buttery, L.; Carpenter, A.; Springall, D.; Polak, J.; Cohen, J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA 1996, 93, 9553–9558. [Google Scholar] [CrossRef] [PubMed]
  43. Abu-Soud, H.M.; Wang, J.; Rousseau, D.L.; Fukuto, J.M.; Ignarro, L.J.; Stuehr, D.J. Neuronal Nitric Oxide Synthase Self-inactivates by Forming a Ferrous-Nitrosyl Complex during Aerobic Catalysis (∗). J. Biol. Chem. 1995, 270, 22997–23006. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Abu-Soud, H.M.; Ichimori, K.; Presta, A.; Stuehr, D.J. Electron transfer, oxygen binding, and nitric oxide feedback inhibition in endothelial nitric-oxide synthase. J. Biol. Chem. 2000, 275, 17349–17357. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Abu-Soud, H.M.; Ichimori, K.; Nakazawa, H.; Stuehr, D.J. Regulation of inducible nitric oxide synthase by self-generated NO. Biochemistry 2001, 40, 6876–6881. [Google Scholar] [CrossRef]
  46. Brown, S.J.; Child, R.B.; Day, S.H.; Donnelly, A.E. Exercise-induced skeletal muscle damage and adaptation following repeated bouts of eccentric muscle contractions. J. Sport. Sci. 1997, 15, 215–222. [Google Scholar] [CrossRef]
  47. Willoughby, D.; McFarlin, B.; Bois, C. Interleukin-6 expression after repeated bouts of eccentric exercise. Int. J. Sport. Med. 2003, 24, 15–21. [Google Scholar] [CrossRef]
  48. Foschini, D.; Prestes, J. Acute hormonal and immune responses after a bi-set strength training. Fit. Perform. J. (Online Ed.) 2007, 6, 38–44. [Google Scholar] [CrossRef]
  49. Wang, J.; Jiang, Z.; Ji, J.; Wang, X.; Wang, T.; Zhang, Y.; Tai, T.; Chen, M.; Sun, L.; Li, X.; et al. Gene expression profiling and pathway analysis of hepatotoxicity induced by triptolide in Wistar rats. Food Chem. Toxicol. 2013, 58, 495–505. [Google Scholar] [CrossRef]
Ijerph 19 16685 g001 550
Figure 1. Effects of triptolide on serum biochemical changes. Rats were randomly divided into five groups. In the normal group (N), rats received 100 μL of saline by intramuscular (i.m.) and 500 μL of saline by intraperitoneal (i.p.) injections. In the carrageenan group (C), rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.). In the carrageenan and triptolide co-treatment groups (CT30, 100, 300), rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Serum LDH (A), CPK (B), GOT (C), and GPT (D) levels were measured 6 h after saline or carrageenan administration by a serum biochemical analyzer. Data are the means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Figure 1. Effects of triptolide on serum biochemical changes. Rats were randomly divided into five groups. In the normal group (N), rats received 100 μL of saline by intramuscular (i.m.) and 500 μL of saline by intraperitoneal (i.p.) injections. In the carrageenan group (C), rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.). In the carrageenan and triptolide co-treatment groups (CT30, 100, 300), rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Serum LDH (A), CPK (B), GOT (C), and GPT (D) levels were measured 6 h after saline or carrageenan administration by a serum biochemical analyzer. Data are the means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Ijerph 19 16685 g001
Ijerph 19 16685 g002 550
Figure 2. Effects of triptolide on pain levels. Rats were divided into three groups. In the N group, rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.). In the C group, rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.). In the CT300 group, rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (300 mg/kg) (i.p.). Animal pain assessment was conducted 6 h after saline or carrageenan administration. Percentage of weight bearing was normalized by the weight on the right limb divided by the total weights of the two hindlimbs Data are the means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Figure 2. Effects of triptolide on pain levels. Rats were divided into three groups. In the N group, rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.). In the C group, rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.). In the CT300 group, rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (300 mg/kg) (i.p.). Animal pain assessment was conducted 6 h after saline or carrageenan administration. Percentage of weight bearing was normalized by the weight on the right limb divided by the total weights of the two hindlimbs Data are the means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Ijerph 19 16685 g002
Ijerph 19 16685 g003 550
Figure 3. Effects of triptolide on muscular nitric oxide (NO) level, myeloperoxidase (MPO) activity, iNOS, lipid hydroperoxide, and glutathione (GSH) expression. Rats were divided into five groups. In group I (N group), rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.); group II (C group) rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.); and groups III-V received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Muscular NO production (A), iNOS (B), MPO (C), lipid hydroperoxide (D), and GSH (E) expression levels were determined 6 h after saline or carrageenan administration. Data are means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Figure 3. Effects of triptolide on muscular nitric oxide (NO) level, myeloperoxidase (MPO) activity, iNOS, lipid hydroperoxide, and glutathione (GSH) expression. Rats were divided into five groups. In group I (N group), rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.); group II (C group) rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.); and groups III-V received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Muscular NO production (A), iNOS (B), MPO (C), lipid hydroperoxide (D), and GSH (E) expression levels were determined 6 h after saline or carrageenan administration. Data are means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Ijerph 19 16685 g003
Ijerph 19 16685 g004 550
Figure 4. Effects of triptolide on muscular TNF-α, IL-1β, phospho-IĸB (p-IĸB), and nuclear NF-ĸB expression. Rats were divided into five groups of six. Group I (N group) rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.); group II (C group) rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.); and groups III-V received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Muscular TNF-α (A), IL-1β (B), p-IĸB (C), and nuclear NF-ĸB (D) were determined 6 h after saline or carrageenan administration. Data are means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Figure 4. Effects of triptolide on muscular TNF-α, IL-1β, phospho-IĸB (p-IĸB), and nuclear NF-ĸB expression. Rats were divided into five groups of six. Group I (N group) rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.); group II (C group) rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.); and groups III-V received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Muscular TNF-α (A), IL-1β (B), p-IĸB (C), and nuclear NF-ĸB (D) were determined 6 h after saline or carrageenan administration. Data are means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group.
Ijerph 19 16685 g004
Ijerph 19 16685 g005 550
Figure 5. Effect of triptolide on histological changes in carrageenan-treated rats. Rats were divided into five groups of six. Group I (N group) rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.); group II (C group) rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.); and groups III-V received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Muscle tissues were collected from N group (A), C group (B), as well as 30 mg/kg (C), 100 mg/kg (D), and 300 mg/kg (E) of triptolide-treated groups. (F) Inflammation score. Data are means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group. Arrows indicate inflammatory cell infiltrates. (Magnification ×100).
Figure 5. Effect of triptolide on histological changes in carrageenan-treated rats. Rats were divided into five groups of six. Group I (N group) rats received 100 μL of saline (i.m.) and 500 μL of saline (i.p.); group II (C group) rats received 100 μL of 3% carrageenan (i.m.) and 500 μL of saline (i.p.); and groups III-V received 100 μL of 3% carrageenan (i.m.) and 500 μL of triptolide (30, 100, and 300 mg/kg, respectively) (i.p.). Muscle tissues were collected from N group (A), C group (B), as well as 30 mg/kg (C), 100 mg/kg (D), and 300 mg/kg (E) of triptolide-treated groups. (F) Inflammation score. Data are means ± standard deviation (SD) (n = 6). * p < 0.05 compared with N group; # p < 0.05 compared with C group. Arrows indicate inflammatory cell infiltrates. (Magnification ×100).
Ijerph 19 16685 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Hsu, C.-C.; Tsai, C.-C.; Ko, P.-Y.; Kwan, T.-H.; Liu, M.-Y.; Wu, P.-T.; Jou, I.-M. Triptolide Attenuates Muscular Inflammation and Oxidative Stress in a Delayed-Onset Muscle Soreness Animal Model. Int. J. Environ. Res. Public Health 2022, 19, 16685. https://doi.org/10.3390/ijerph192416685

AMA Style

Hsu C-C, Tsai C-C, Ko P-Y, Kwan T-H, Liu M-Y, Wu P-T, Jou I-M. Triptolide Attenuates Muscular Inflammation and Oxidative Stress in a Delayed-Onset Muscle Soreness Animal Model. International Journal of Environmental Research and Public Health. 2022; 19(24):16685. https://doi.org/10.3390/ijerph192416685

Chicago/Turabian Style

Hsu, Che-Chia, Chin-Chuan Tsai, Po-Yen Ko, Ting-Hsien Kwan, Ming-Yie Liu, Po-Ting Wu, and I-Ming Jou. 2022. "Triptolide Attenuates Muscular Inflammation and Oxidative Stress in a Delayed-Onset Muscle Soreness Animal Model" International Journal of Environmental Research and Public Health 19, no. 24: 16685. https://doi.org/10.3390/ijerph192416685

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop